AstraZeneca
AZN
#47
Rank
โ‚น25.098 T
Marketcap
โ‚น8,095
Share price
-1.27%
Change (1 day)
42.38%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น734.93 Billion

According to AstraZeneca's latest financial reports the company has โ‚น734.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น473.97 B-2.84%
2023-12-31โ‚น487.83 B-5.57%
2022-12-31โ‚น516.60 B8.48%
2021-12-31โ‚น476.21 B-18.52%
2020-12-31โ‚น584.48 B31.84%
2019-12-31โ‚น443.34 B13.34%
2018-12-31โ‚น391.14 B34.52%
2017-12-31โ‚น290.77 B-26.36%
2016-12-31โ‚น394.88 B-11.88%
2015-12-31โ‚น448.10 B0.42%
2014-12-31โ‚น446.24 B-26.99%
2013-12-31โ‚น611.25 B35.76%
2012-12-31โ‚น450.23 B-24.52%
2011-12-31โ‚น596.50 B12.57%
2010-12-31โ‚น529.87 B0.16%
2009-12-31โ‚น529.05 B150.67%
2008-12-31โ‚น211.05 B-9.74%
2007-12-31โ‚น233.82 B-31.29%
2006-12-31โ‚น340.32 B51.89%
2005-12-31โ‚น224.05 B-1.74%
2004-12-31โ‚น228.01 B26.75%
2003-12-31โ‚น179.88 B-19.98%
2002-12-31โ‚น224.81 B21.87%
2001-12-31โ‚น184.46 B-11.23%
2000-12-31โ‚น207.80 B45.38%
1999-12-31โ‚น142.93 B-1.47%
1998-12-31โ‚น145.07 B206.32%
1997-12-31โ‚น47.36 B-21.1%
1996-12-31โ‚น60.02 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bristol-Myers Squibb
BMY
โ‚น1.482 T 101.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.345 T 83.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.21 B-45.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚น938.83 B 27.74%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
โ‚น890.47 B 21.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.667 T 126.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น694.60 B-5.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น355.73 B-51.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น876.05 B 19.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland